Salts of 5-amino-2-sulfonamide-1,3,4-thiadiazole, a structural and analog of acetazolamide, show interesting carbonic anhydrase inhibitory properties, diuretic, and anticonvulsant action

References

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Conway J, eds. Carbonic anhydrase—its inhibitors and activators. Boca Raton, New York, London: CRC Press; 2004:1–363
   Google Scholar
• Temperini C, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited-old leads for new applications? Org Biomol Chem 2008;6:2499–506
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199–229
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Development of sulfonamide carbonic anhydrase inhibitors. In: Supuran CT, Scozzafava A, Conway J, eds. Carbonic anhydrase—its inhibitors and activators. Boca Raton: CRC Press; 2004:67–147
   Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO(2) capture. J Enzyme Inhib Med Chem 2013;28:229–30
   PubMed Web of Science ®Google Scholar
• Nishimori I, Onishi S, Takeuchi H, Supuran CT. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr Pharm Des 2008;14:622–30
   PubMed Web of Science ®Google Scholar
• Casini A, Antel J, Abbate F, et al. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett 2003;13:841–5
   PubMed Web of Science ®Google Scholar
• De Simone G, Di Fiore A, Menchise V, et al. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg Med Chem Lett 2005;15:2315–20
   PubMed Web of Science ®Google Scholar
• Winum JY, Dogne JM, Casini A, et al. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides – a new zinc-binding function in the design of inhibitors. J Med Chem 2005;48:2121–5
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Passaponti M, Supuran CT, Gulcin I. Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). J Enzyme Inhib Med Chem 2015;30:586–91
   PubMed Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793–810
   PubMed Web of Science ®Google Scholar
• Cecchi A, Hulikova A, Pastorek J, et al. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J Med Chem 2005;48:4834–41
   PubMed Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793–810
   PubMed Web of Science ®Google Scholar
• Pedregosa JC, Alzuet G, Borrás J, et al. Structure of 5-amino-1,3,4-thiadiazole-2-sulfonamide, an inhibitor of the enzyme carbonic anhydrase. Acta Cryst 1993;C49:630–3
   Google Scholar
• Pedregosa JC, Casanova J, Alzuet G, et al. Metal complexes of 5-tertbutyloxycarbonylamido-1,3,4-thiadiazole-2-sulfonamide (B-H2ats), a carbonic anhydrase inhibitor. Synthesis and characterization of the copper(II) complex. Crystal structures of B-H2ats and the [Cu(B-ats)(NH3)2]2 dimer complex. Inorg Chim Acta 1995;232:117–24
   Web of Science ®Google Scholar
• Camí GE, Server-Carrió J, Fustero S, Pedregosa JC. A novel heterocyclic sulfonamide: N-benzyl-5-[N-benzyl-N-(tert-butyloxycarbonyl)amino]-N-(tert-butyloxycarbonyl)-1,3,4-thiadiazole-2-sulfonamide. Acta Crystallogr C 2000;56:E209–10
   PubMedGoogle Scholar
• Camí GE, Ramírezde Arellano MC, Supuran CT, et al. Optimal synthetic route and structural characterization of new 1,3,4-thiadiazole-5-N-substituted-sulfonamides. J Arg Chem Soc 2006;94:5–17
   Google Scholar
• Chufán EE, Pedregosa JC, Baldini OL, Bruno-Blanch L. Anticonvulsant activity of analogues of acetazolamide. Il Farmaco 1999;54:838–41
   PubMedGoogle Scholar
• Diaz JRA, Camí GE, Liu-González M, et al. Two novel potential anticonvulsant salts of 5-amino-2-sulfonamide-1,3,4-thiadiazole. J Chem Crystallogr 2011;41:1114–19
   Web of Science ®Google Scholar
• Camí GE, Chufán EE, Pedregosa JC, Varetti EL. Infrared and Raman spectra of 5-amino-1,3,4-thiadiazole-2-sulfonamide (Hats). Experimental data and quantum chemistry calculations. J Mol Struct 2001;570:119–27
   Web of Science ®Google Scholar
• Nonius (1997–2000). COLLECT. Delft, The Netherlands: Nonius BV
   Google Scholar
• Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. In: Carter CW Jr, Sweet RM, eds. DENZO and SCALEPACK. Methods in enzymology, vol 276, Macromolecular crystallography, PartA. San Diego: Academic Press; 1997:307–26
   Google Scholar
• Sheldrick GM. SHELXL97 and SHELXS97 programs for crystal structure refinement and solution. University of Göttingen, Germany. Acta Cryst 2008;A64:112–22
   Web of Science ®Google Scholar
• Farrugia LJ. Win GX. J Appl Cryst 1999;32:837–8
   Web of Science ®Google Scholar
• Farrugia LJ. ORTEP-3 for Windows. J Appl Cryst 1997;30:565–6
   Web of Science ®Google Scholar
• Administración Nacionalde Medicamentos,A limentosy Tecnología (ANMAT) Disposición 6344/96. Reglamentaciónpara Bioteriosdelaboratorioselaboradoresdeespecialidadesmedicinalesy/odeanálisisdeterceros
   Google Scholar
• Lipschitz WL, Hadidian Z, Kerpesar A. Bioassay of diuretics. J Pharmacol Exp Ther 1943;79:97–110
   Google Scholar
• Jackson EK. Drugs affecting renal and cardiovascular function. In: Hardman JC, Gilman AG, Limbird LE, eds. Goodman and Gilman’s the pharmacological basis of therapeutics, 10th ed. New York: Pergamon Press; 1996:685–713
   Google Scholar
• Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 1957;46:208–10
   PubMed Web of Science ®Google Scholar
• Boissier JR, Tardy J, Diverres JC. Une novelle methode simple pour explorer l′action �tranquillisante�: le test de la cheminee. Med Exp 1960;3:81–4
   Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of Carbonic Anhidrase. I. Stop flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–74
   PubMed Web of Science ®Google Scholar
• Alafeefy AM, Ceruso M, Al-Jaber NA, et al. A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi. J Enzyme Inhib Med Chem 2015;30:581–5
   PubMed Web of Science ®Google Scholar
• Carta F, Di Cesare Mannelli L, Pinard M, et al. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. Bioorg Med Chem 2015;23:1828–40
   PubMed Web of Science ®Google Scholar
• Prestch E, Clerc T, Seibl J, Simon W. Tablasparaladilucidaciónestructuraldecompuestosorgánicospormétodosespectroscópicos:¹³CRMN,¹H-RMN,IR,EM,UV-Vis. Barcelona, España: Singer Verlag-Ibérica; 1998
   Google Scholar
• GraphPad Prism, Graphpad Software Inc., Copyright 1994–2000v3.02
   Google Scholar
• Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun (Camb) 2012;48:1868–70
   PubMed Web of Science ®Google Scholar
• Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Bioorg Med Chem Lett 2008;18:1583–7
   PubMed Web of Science ®Google Scholar
• Innocenti A, Vullo D, Scozzafava A, et al. Carbonic anhydrase inhibitors. Interaction of isozymesI, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett 2005;15:573–8
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Monti SM, Hilvo M, et al. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins 2009;74:164–75
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233–45
   PubMed Web of Science ®Google Scholar
• Supuran CT. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. Curr Med Chem 2012;19:831–44
   PubMed Web of Science ®Google Scholar
• Sahin H, Can Z, Yildiz O, et al. Inhibition of carbonic anhydrase isozymes I and II with natural products extracted from plants, mushrooms and honey. J Enzyme Inhib Med Chem 2012;27:395–402
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Menabuoni L, Mincione F, et al. Carbonic anhydrase inhibitors. Synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties. Bioorg Med Chem Lett 2001;11:575–82
   PubMed Web of Science ®Google Scholar
• Supuran CT, Casini A, Mastrolorenzo A, Scozzafava A. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents. Mini Rev Med Chem 2004;4:625–32
   PubMed Web of Science ®Google Scholar
• De Simone G, Di Fiore A, Supuran CT. Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? Curr Pharm Des 2008;14:655–60
   PubMed Web of Science ®Google Scholar